ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0644

Long-lived Plasma Cells in the Lupus Bone Marrow Are Imprinted by Interferon

Jennifer Barnas1, Diana Alzamareh2, Neha Nandedkar-Kulkarni2, Jennifer Albrecht2, Nida Meednu2, Cameron Baker2, Andrew McDavid1 and Jennifer Anolik2, 1University of Rochester, Rochester, NY, 2University of Rochester Medical Center, Rochester, NY

Meeting: ACR Convergence 2022

Keywords: B-Cell Targets, B-Lymphocyte, Gene Expression, interferon, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: SLE – Etiology and Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Systemic lupus erythematous (SLE) is a complex autoimmune disorder with heterogeneous disease presentation and a multi-pronged pathogenesis. Although autoreactive plasma cells (PC) play a key role in SLE, they are still elusive targets. In particular, bone marrow (BM) PC represent a long-lived (LL) pool that may be particularly difficult to eliminate. In order to define the signals that promote the survival of LLPCs in lupus BM, we performed transcriptomic analysis on sorted human BM populations.

Methods: Human CD19+CD27hiCD38hi blood plasmablasts (PB), CD19+CD27hiCD38hiCD138+ BM mature PCs and CD19–CD27hiCD38hiCD138+ BM long-lived PCs (LLPC) were sorted for transcriptomic analysis (controls: n = 7 and SLE: n = 9). The impact of interferon (IFN-α2) on antibody secretion and PC survival was assessed by IgG ELISPOT, ELISA (n=5), and annexin V-propidium iodide flow cytometry-based apoptosis assay (n=3). STAT1 phosphorylation fold change (FC) after IFN-α2 stimulation was measured by flow cytometry median fluorescent intensity (n=3).

Results: In transcriptomic analysis, BM PCs showed up-regulation of NFkB signaling and extra-cellular matrix receptor interactions, and down-regulation of cell cycle signaling pathways, compared to blood PC (gene pathway enrichment analysis). Going along with this difference in transcriptomic profile, BM PCs had a higher survival in vitro compared to blood PB. PCs in the lupus BM, including the putative long-lived PC, had a prominent IFN signature compared to those of healthy controls. We next asked whether BM PC can respond to IFN. Indeed, both BM LLPCs (CD19- Ig+ CD27hi CD38hi) and PB/PC (CD19+ Ig+ CD27hi CD38hi) had increased STAT1 phosphorylation in response to IFN-α2 stimulation (FC for IgG+ BM LLPC: 5.07±0.97 in HD, 3.89±0.45 in SLE and for IgG+ BM PB/PC 4.35±0.86 in HD, 4.02±0.62 in SLE). However, IFN-α2 treatment did not alter IgG secretion or PC survival in in vitro culture experiments.

Conclusion: Our data highlights the importance of bone marrow microenvironment signals for PC survival. The pronounced IFN signature in the lupus BM suggests that IFN may be a key mediator of autoreactive PC longevity in SLE. We are currently investigating the impact of alternative interferons alone and in combination with other signals on PC survival and function.


Disclosures: J. Barnas, None; D. Alzamareh, None; N. Nandedkar-Kulkarni, Large Molecule Research, Sanofi U.S. Services; J. Albrecht, Cellectis Biologicals; N. Meednu, None; C. Baker, None; A. McDavid, None; J. Anolik, None.

To cite this abstract in AMA style:

Barnas J, Alzamareh D, Nandedkar-Kulkarni N, Albrecht J, Meednu N, Baker C, McDavid A, Anolik J. Long-lived Plasma Cells in the Lupus Bone Marrow Are Imprinted by Interferon [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/long-lived-plasma-cells-in-the-lupus-bone-marrow-are-imprinted-by-interferon/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/long-lived-plasma-cells-in-the-lupus-bone-marrow-are-imprinted-by-interferon/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology